AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Aventis | Sanofi | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Biovail | Bausch Health | False Claims Act and related | 2013 | LA-AG | $200,000 |
Boehringer Ingelheim | Boehringer Ingelheim | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Boehringer Ingleheim | Boehringer Ingelheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $187,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Cephalon, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
Daiichi Sankyo, Inc. | Daiichi Sankyo | False Claims Act and related | 2015 | MULTI-AG | $39,000,000 |
Dava Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
Dey | Viatris | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Dey Inc. | Viatris | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
Dey Inc. | Viatris | False Claims Act and related | 2004 | WV-AG | $850,000 |
Dey L.P. | Viatris | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Dey Labs | Viatris | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Dey LP | Viatris | False Claims Act and related | 2007 | MT-AG | $198,000 |
Dey Pharmaceuticals | Viatris | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | NV-AG | $670,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Eisai | Eisai | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
Eli Lilly | Eli Lilly | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
EMD Serono, Inc. | Merck KGaA (EMD) | False Claims Act and related | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $44,300,000 |
Endo Health Solutions | Endo International | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
Endo Pharmaceuticals | Endo International | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
Forest Laboratories | AbbVie | False Claims Act and related | 2013 | TX-AG | $3,000,000 |
Forest Laboratories LLC | AbbVie | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,500,000 |
Forest Laboratories, Inc. | AbbVie | False Claims Act and related | 2012 | ID-AG | $790,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $60,000,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
Genentech Inc. | Roche | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Genzyme Corp. | Sanofi | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $22,280,000 |
Gilead Sciences | Gilead Sciences | False Claims Act and related | 2013 | LA-AG | $250,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2003 | MULTI-AG | $40,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2005 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,000,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2006 | GA-AG | $418,952 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2011 | KS-AG | $4,250,000 |
GlaxoSmithKline | GlaxoSmithKline | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
GlaxoSmithKline LLC | GlaxoSmithKline | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Glenmark Generics Inc. | Glenmark Pharmaceuticals | False Claims Act and related | 2015 | TX-AG | $13,750,000 |
Immunex Corp. | Amgen | False Claims Act and related | 2009 | IA-AG | $357,000 |
IVAX Pharmaceuticals | Teva Pharmaceutical Industries | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $5,400,000 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
Johnson & Johnson et al. | Johnson & Johnson | False Claims Act and related | 2010 | HI-AG | $5,200,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
King Pharmaceuticals | Pfizer | False Claims Act and related | 2006 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $124,000,000 |
Lupin Pharmaceuticals | Lupin Limited | False Claims Act and related | 2013 | LA-AG | $750,000 |
Mallinckrodt LLC | Mallinckrodt | False Claims Act and related | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Merck | Merck | False Claims Act and related | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $290,000,000 |
Merck & Co., Inc. | Merck | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
Merck and Company, Inc. | Merck | False Claims Act and related | 2011 | WI-AG | $4,250,000 |
Merck Sharp & Dohme Corp | Merck | False Claims Act and related | 2010 | HI-AG | $28,000,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $1,600,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2012 | KY-AG | $6,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $465,000,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Mylan Laboratories Inc. | Viatris | False Claims Act and related | 2010 | TX-AG | $23,000,000 |
Mylan Laboratories Inc. And Mylan Pharmaceuticals Inc. | Viatris | False Claims Act and related | 2012 | ID-AG | $625,000 |
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2011 | KY-AG | $6,500,000 |
Mylan Pharmaceuticals, Inc. | Viatris | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $118,000,000 |
Novartis | Novartis | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2013 | ID-AG | $750,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
Novartis Pharmaceuticals Corporation | Novartis | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,320,963 |
Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,400,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | DOJ_CIVIL | $33,500,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Par Pharmaceutical | Endo International | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Par Pharmaceutical Co. | Endo International | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Par Pharmaceutical Cos., Inc. | Endo International | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Par Pharmaceutical Inc. | Endo International | False Claims Act and related | 2011 | KY-AG | $4,500,000 |
Par Pharmaceutical, Inc. | Endo International | False Claims Act and related | 2010 | MA-AG | $500,000 |
Par Pharmaceuticals, Inc. | Endo International | False Claims Act and related | 2011 | MULTI-AG | $154,000,000 |
Pernix Therapeutics | Currax Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |